PharmacyCodes



Azlocillinum [INN-Latin] en es it fr

Azlocillinum [INN-Latin] Brand names, Azlocillinum [INN-Latin] Analogs

Azlocillinum [INN-Latin] Brand Names Mixture

  • No information avaliable

Azlocillinum [INN-Latin] Chemical_Formula

C20H23N5O6S

Azlocillinum [INN-Latin] RX_link

No information avaliable

Azlocillinum [INN-Latin] fda sheet

Azlocillinum [INN-Latin] msds (material safety sheet)

Azlocillinum_[INN-Latin] MSDS

Azlocillinum [INN-Latin] Synthesis Reference

No information avaliable

Azlocillinum [INN-Latin] Molecular Weight

461.493 g/mol

Azlocillinum [INN-Latin] Melting Point

No information avaliable

Azlocillinum [INN-Latin] H2O Solubility

Sodium salt is soluble in water (50 mg/ml)

Azlocillinum [INN-Latin] State

Solid

Azlocillinum [INN-Latin] LogP

-0.046

Azlocillinum [INN-Latin] Dosage Forms

Solution (for intramuscular injection or intravenous infusion)

Azlocillinum [INN-Latin] Indication

For the treatment of infections caused by Pseudomonas aeruginosa, Escherichia coli, and Haemophilus influenzae.

Azlocillinum [INN-Latin] Pharmacology

Azlocillin, similar to mezlocillin and piperacillin, is an acylampicillin with an extended spectrum of activity and greater in vitro potency than the carboxy penicillins. Azlocillin demonstrates antibacterial activity against a broad spectrum of bacteria, including Pseudomonas aeruginosa, and, in contrast to most cephalosporins, exhibits activity against enterococci.

Azlocillinum [INN-Latin] Absorption

Not significantly absorbed from the gastrointestinal tract.

Azlocillinum [INN-Latin] side effects and Toxicity

No information avaliable

Azlocillinum [INN-Latin] Patient Information

Azlocillinum [INN-Latin] Organisms Affected

Enteric bacteria and other eubacteria